Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TRIM52 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PCSK7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
NPIPA5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
MALAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FTX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PCBP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENOSF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC18-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PSMB2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CTC-338M12.4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPA3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
U2AF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FKBP11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HNRNPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DLG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SULT1A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on